News & Updates

Kyle Kostesich 2/29/24 Kyle Kostesich 2/29/24

Cortigent has filed amended documents for its planned IPO

Cortigent has filed amended documents for its planned IPO. The S-1/A Prospectus and Free Writing Prospectus slide deck may be accessed at SEC.gov.

Read More

Kyle Kostesich 9/5/23 Kyle Kostesich 9/5/23

Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10

Read More

Kyle Kostesich 8/16/23 Kyle Kostesich 8/16/23

Second Sight’s Implant Technology Gets a Second Chance

IEEE Spectrum profiles Cortigent, detailing how it will develop brain implants for vision and stroke rehabilitation.

Read More

Kyle Kostesich 7/17/23 Kyle Kostesich 7/17/23

Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System

Read More

Kyle Kostesich 7/6/23 Kyle Kostesich 7/6/23

Cortigent featured in Engineering & Technology article, “A Vision for Future”

The article dives into breakthroughs in human and machine vision and discusses how Cortigent is leaving its mark.

Read More

Kyle Kostesich 3/21/23 Kyle Kostesich 3/21/23

Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division

Read More

Kyle Kostesich 11/14/22 Kyle Kostesich 11/14/22

Vivani Medical Reports Third Quarter 2022 Results and Provides Business Updates

Read More

Kyle Kostesich 8/30/22 Kyle Kostesich 8/30/22

Second Sight Medical Products Announces Successful Completion of its Merger with Nano Precision Medical and its Name Change to Vivani Medical, Inc.

Read More

Kyle Kostesich 7/18/22 Kyle Kostesich 7/18/22

Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study

Read More